The IV therapy industry, valued at an estimated $15 billion, serves millions across diverse settings. These services are offered in brick-and-mortar establishments—often integrated with other wellness businesses such as facial spas or providers of red-light therapy—and through mobile units that visit homes, hotels, and workplaces. The menu of offerings is expansive, ranging from hangover recovery and immunity boosts to cold and flu remedies and beauty enhancements.

The American Medical Spa Association provides “legal, business and clinical training resources to build legally compliant, profitable and safe medical aesthetic practices.”

However, One of the most significant concerns surrounding these types of IV therapy is the lack of FDA approval for many of these treatments. Unlike medications and therapies that undergo rigorous testing and approval, IV therapy offered by these boutique clinics often lacks evidence that it is safe and effective. This absence of oversight means the ingredients in IV bags and the qualifications of those preparing the IV bags and/or administering them can vary widely, posing potential risks to your health.

In this webinar Mary Nazzal and Kate Douglass will familiarize the audience with three major issues for the public and regulators alike:

• Scope of practice related to prescribers, nursing and others

• Prescriber oversight and medical appropriateness of offerings

• Common compounding practices in med spas and safe compounding recommendations

Webinar Resources

• The IV Med Spa Industry Promise and Pitfalls